Anna Törner: “My quantified life”

“The expression ‘you can’t see the forest for the trees’ feels newly relevant in the context of wearables. One can easily get caught up in the idea that the mor...

5 viktiga saker att tänka på när du väljer ERP-leverantör

Att välja ett nytt ERP-system är ett av de viktigaste besluten ett tillverkande eller distribuerande företag kan fatta. Misslyckade implementationer, oväntade k...

XV-serien - Modulär ventilterminal från Aventics

OEM Automatic lanserar nu Aventics XV-serie från Emerson – en modulär ventilterminal som kombinerar hög prestanda med kompakta mått. Serien är framtagen för att...

Bio Europe to Stockholm – ”The Swedish ecosystem is now taking the opportunity”

The international life science conference Bio Europe is coming to Sweden for the first time in November. The conference, whose program takes inspiration from AB...

Drug development booms in Medicon Valley

When it comes to developing new medicines, the Öresund region is one of the top performers in the EU. Companies working on commission for pharmaceutical compani...

Join our measuringhero Jay on the innovation tour

Experience our latest innovation from the Control fair.

Final assembly inspection of medical plastics

Technical paper by ZEISS Medical Industry Solutions.

Unmatched performance and flexibility in its class

The new ZEISS SPECTRUM family is equipped to be the ideal match from measuring small electronics up to larger housings.

About Microscope Ergonomics

Learn about ergonomic microscope design and how you can increase your well-being and productivity when working in clinical microscopy. Read about challenges, de...

Xbrane enters licensing agreement with Indian generics giant

Swedish biosimilar developer Xbrane Biopharma and the Indian company Intas Pharmaceuticals have entered into a license and co-development agreement.

Lonza

600 million SEK for life science - "Should not be the country of moderation"

Sweden will prioritize excellence over breadth in research. This was made clear when the government presented the research proposition for the next four years.

Norwegian cancer research companies merge

The Norwegian companies Ultimovacs and Zelluna Immunotherapy plan to merge. At the same time, it is made clear that Ultimovacs' CEO is leaving the company.

Aurevia

One last chance to register for the premier metrology event in 2024

ZEISS QUALITY INNOVATION SUMMIT.

Alvotech utser Linda Jónsdóttir till ny finanschef

Linda Jónsdóttir har utsetts till ny Chief Financial Officer (CFO) på isländska Alvotech, noterade på Stockholmsbörsen.

ZEISS presents the "Quality Innovation Days"

The digital event for metrology and software.

The new Swedish life science strategy – “It will consolidate Sweden as a leader”

Clinical trials and precision health are emphasised as key areas in the new national life science strategy.

Stockholm and Uppsala jointly form a life science cluster

Stockholm and Uppsala are strengthening cooperation in medical research and biotech.

Life science trends 2025 – The economy

Upcoming patent expirations are driving pharmaceutical companies to acquire in 2025. In Sweden, we may be on our way to brighter times and fewer bankruptcies. T...

It couldn’t be simpler

AI-assisted ZEISS Solution inspects implant coatings automatically.

”The importance of stratification in a statistician’s August kitchen”

Ingrid Lönnstedt writes about an experiment of her own at home and about what lessons can be learned from it, in a science column.

Standardisation in automation

, reduced operating costs. And it worked. With support from Festo.

Hypothesis testing versus conspiracy theory

"How do you know what is a conspiracy theory and what is a reasonable, scientifically based conclusion?" In a column, Ingrid Lönnstedt reflects on this question.